COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

NCL News Archive

Tuesday, December 6, 2016

Nature Reviews publication

The NCL has recently published a review article entitled “Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer” in Nature Reviews Clinical Oncology. The review highlights current nanomedicine strategies being used to target one of the most devastating cancers.

Find the Advance Online publication here: View Post

Monday, November 28, 2016

Nanomedicine Pharmacokinetics Publication

NCL’s Sr. Principal Scientist in Pharmacology & Toxicology, Dr. Stephan Stern, has spearheaded several important publications on the complexity of nanomedicine pharmacokinetics and the importance of measuring all drug fractions—nanomedicine encapuslated, protein-bound, and free unbound drug—when evaluating nanomedicine PK. The most recent of these publications is entitled “When Is It... View Post

Monday, November 28, 2016

NCL Lessons Learned Workshop Videocast

The NCL recently hosted its 8th edition of the popular Lessons Learned Workshop (LLW) seminar series. This year’s meeting was condensed into an intensive half-day series of talks covering topics such as strategies for evaluating batch-to-batch consistency, surface characterization, nanomaterial ADME/Tox and PK, sterility and endotoxin contamination, immunotoxicity, and linking physicochemical... View Post

Monday, September 26, 2016

AAPS Journal Themed Issue

The AAPS Journal is compiling a themed issue entitled “Nanotechnology in Complex Drug Products: Learning from the Past, Preparing for the Future.” The issues aims to discuss characterization, manufacturing, and regulatory challenges in nanotechnology drug products. NCL’s contribution to this collection, “Early Development Challenges for Drug Products Containing Nanomaterials” has just been... View Post